封面
市場調查報告書
商品編碼
1448257

全球鼻插管市場:市場規模、佔有率、成長分析 - 按類型、應用、產業預測(2024-2031)

Global Nasal Cannula Market Size, Share, Growth Analysis, By Type(Low Flow and high flow), By Application(Hospitals, ambulatory health services) - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球鼻插管市場規模將達72.4億美元,2023年將達到76.5億美元,2024-2031年預測期間複合年成長率為6.4%,2031年將達到118.2億美元。

近年來,全球鼻插管市場經歷了顯著的成長和進步。鼻插管是一種廣泛使用的醫療設備,在為呼吸困難或需要呼吸輔助的患者提供補充氧氣方面發揮重要作用。市場動力受到多種因素的推動,包括慢性阻塞性肺病(COPD)、氣喘和睡眠呼吸中止症等呼吸系統疾病盛行率的上升。此外,人口老化、醫療保健支出增加以及家庭醫療保健服務需求的快速成長是市場擴張的進一步推動力。

不斷的技術進步帶來了創新的鼻插管,這些插管具有更高的舒適度、卓越的氧氣輸送效率和更高的患者依從性。此外,COVID-19 大流行的爆發擴大了對鼻插管的需求,特別是在患有呼吸道併發症的患者中。

市場格局的特點是存在許多積極從事研發以推出先鋒產品並保持競爭力的主要企業。由於呼吸道疾病的高發病率和有利的報銷政策,北美傳統上主導全球鼻插管市場,但亞太地區預計在預測期內將大幅成長。這一成長將由醫療基礎設施的擴大、對呼吸系統疾病的認知的提高以及獲得醫療服務的機會的增加所推動。

綜上所述,由於技術進步、呼吸系統疾病發病率上升以及對有效呼吸護理解決方案的需求不斷成長,預計全球鼻插管市場在可預見的未來將保持上升趨勢。

目錄

執行摘要

  • 市場概況
  • 命運之輪

調查方法

  • 資訊採購
  • 次要/主要資料來源
  • 市場規模估算
  • 市場假設/限制

母市場分析

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務

主要市場考察

  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 智慧財產權分析
  • 貿易分析
  • Start-Ups分析
  • 原料分析
  • 創新矩陣
  • 研發線產品分析
  • 總體經濟指標
  • 主要投資分析
  • 關鍵成功因素
  • 競爭程度

市場動態及展望

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 監管環境
  • 波特的分析
  • 對未來中斷的特殊考慮

全球鼻插管市場:按類型

  • 市場概況
  • 低流量/高流量

全球鼻插管市場:依應用分類

  • 市場概況
  • 醫院
  • 門診醫療服務
  • 長期照護中心

全球鼻插管市場規模:按地區

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中東/非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲

競爭格局

  • 前5名企業對比
  • 主要企業市場定位(2021年)
  • 主要市場參與者所採取的策略
  • 關鍵成功策略
  • 近期市集活動
  • 主要企業市場佔有率(2021年)

主要企業簡介

  • Allied Healthcare Products, Inc.(US)
  • Teleflex Incorporated(US)
  • Flexicare Medical Ltd.(UK)
  • Vapotherm Inc.(US)
  • ResMed Inc.(US)
  • Fairmont Medical(Australia)
  • Fisher & Paykel Healthcare Limited(New Zealand)
  • Well Lead Medical Co. Ltd.(China)
  • Salter Labs(US)
  • Hamilton Medical AG(Switzerland)
  • Drive DeVilbiss Healthcare(US)
  • Vygon(France)
  • Besmed Health Business Corp.(Taiwan)
  • Smiths Medical(UK)
  • Great Group Medical Co. Ltd.(Taiwan)
  • MAQUET Holding BV & Co. KG(Germany)
  • Flexicare Medical(US)
  • Progetti Srl(Italy)
  • Pulmodyne(US)
  • GALEMed Corporation(Taiwan)
簡介目錄
Product Code: SQMIG35A2292

Global Nasal Cannula Market size was valued at USD 7.24 billion in 2022 and is poised to grow from USD 7.65 billion in 2023 to USD 11.82 billion by 2031, growing at a CAGR of 6.4% during the forecast period (2024-2031).

In recent years, the global market for nasal cannulas has experienced notable growth and advancements. Nasal cannulas, widely utilized medical devices, play a crucial role in delivering supplemental oxygen to patients encountering respiratory difficulties or necessitating respiratory support. The market's momentum is propelled by various factors, including the escalating prevalence of respiratory ailments like chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea. Moreover, an aging population, augmented healthcare spending, and the surging demand for home healthcare services further fuel market expansion.

Continuous technological progress has resulted in the emergence of innovative nasal cannulas boasting enhanced comfort, superior oxygen delivery efficiency, and improved patient adherence. Furthermore, the onset of the COVID-19 pandemic has amplified the requirement for nasal cannulas, particularly among patients grappling with respiratory complications.

The market landscape is characterized by the presence of numerous key players actively involved in research and development initiatives to introduce pioneering products and maintain a competitive stance. While North America has traditionally dominated the global nasal cannula market, owing to its high prevalence of respiratory ailments and favorable reimbursement policies, the Asia Pacific region is poised for significant growth in the forecast period. This growth is fueled by the expanding healthcare infrastructure, heightened awareness regarding respiratory diseases, and enhanced access to healthcare services.

In summary, the global nasal cannula market is anticipated to sustain its upward trajectory in the foreseeable future, driven by advancements in technology, escalating respiratory disorders, and the escalating demand for effective respiratory care solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nasal Cannula Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nasal Cannula Market Segmental Analysis

There are three segments in the global nasal cannula market: type, application, and geography. The market can be divided into Low Flow and High Flow segments based on type. The market is divided into segments according to application, including long-term care facilities, hospitals, and ambulatory health services. The market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America based on geographic factors.

Drivers of the Global Nasal Cannula Market

The rising incidence of respiratory illnesses is one of the major factors propelling the worldwide nasal cannula market. The need for respiratory support and oxygen therapy is increasing due to the increased prevalence of diseases like chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea worldwide. This is propelling the expansion of the nasal cannula market.

Restraints in the Global Nasal Cannula Market

The existence of substitute respiratory support equipment is a major commercial barrier. Although nasal cannulas are a common and useful tool, there are more sophisticated respiratory support alternatives available with mechanical ventilators and non-invasive ventilation (NIV) devices. Depending on how severe their respiratory disease is, certain patients might need these other devices, which in some circumstances could limit the nasal cannula market's potential for growth.

Market Trends of the Global Nasal Cannula Market

The growing use of high-flow nasal cannulas is a significant industry trend in the nasal cannula market globally. Patients with severe respiratory disorders can benefit from enhanced oxygenation and respiratory support thanks to high-flow nasal cannulas, which give a much higher flow rate of oxygen. The increased awareness of the advantages provided by high-flow nasal cannulas-such as increased patient comfort, less respiratory effort, and enhanced inspired air humidification-is what is causing this trend. The market for nasal cannulas is growing generally because more and more high-flow nasal cannulas are being used in different healthcare settings, such as emergency rooms, intensive care units, and hospitals.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Nasal Cannula Market by Type

  • Market Overview
  • Low Flow and high flow

Global Nasal Cannula Market by Application

  • Market Overview
  • Hospitals
  • ambulatory health services
  • long term care centres and others

Global Nasal Cannula Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Allied Healthcare Products, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Flexicare Medical Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vapotherm Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ResMed Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fairmont Medical (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fisher & Paykel Healthcare Limited (New Zealand)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Well Lead Medical Co. Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Salter Labs (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hamilton Medical AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Drive DeVilbiss Healthcare (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vygon (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Besmed Health Business Corp. (Taiwan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smiths Medical (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Great Group Medical Co. Ltd. (Taiwan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MAQUET Holding B.V. & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Flexicare Medical (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Progetti S.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pulmodyne (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GALEMed Corporation (Taiwan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments